REPERFUSION INJURY

Clinical trials for REPERFUSION INJURY explained in plain language.

Never miss a new study

Get alerted when new REPERFUSION INJURY trials appear

Sign up with your email to follow new studies for REPERFUSION INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 3

New drug trial aims to protect hearts during attack treatment

Disease control Not yet recruiting

This study tests whether a single dose of Xolatryp given during emergency heart attack treatment can improve recovery. 300 adults having a severe heart attack will receive either Xolatryp or a placebo infusion during their procedure. Researchers will monitor heart health for 30 d…

Matched conditions: REPERFUSION INJURY

Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

REPERFUSION INJURY

Get alerted when new REPERFUSION INJURY trials appear

New drug trial aims to protect hearts during attack treatment